ARCHIVES

ODAC Member Critical Of Amgen For Price Incentives.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

August 19, 1983

DCE Board Approves Recompetitions, Program Announcement For Research On Fish

July 7, 1989

City of Hope CEO Michael Friedman: Cancer Centers Must Adapt; “Not Losing Sleep” Over Sequestration

April 5, 2013

MRI, 3D Ultrasound Combination Can Guide Prostate Biopsies

December 28, 2012

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 12, 1990

NCCS Selects New President

October 9, 2009